Pancreatic Cancer Research

ResearcherVanderbilt UniversityActive in the last 2 years

Wei Zheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1226-070X; OpenAlex author ID A5100401143, A5132876963. Sources: OpenAlex.

Their work

Papers
38 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
85
Papers, trials and grants by year

2013: 3 papers · 2014: 2 papers · 2015: 3 papers · 2016: 1 paper · 2017: 1 paper · 2018: 5 papers · 2019: 1 paper · 2020: 6 papers · 2021: 6 papers · 2022: 1 paper · 2023: 1 paper · 2024: 3 papers · 2025: 2 papers · 2026: 3 papers

Papers 38

  1. Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models. Co-author DOI 10.1038/s41698-026-01479-x↗
  2. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
  3. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  4. Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33. Co-author DOI 10.1038/s41467-025-59109-2↗
  5. Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America. Co-author DOI 10.1371/journal.pmed.1004590↗
  6. Circulating microRNAs in association with pancreatic cancer risk within 5 years. Co-author DOI 10.1002/ijc.34956↗
  7. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-24-0096↗
  8. Identification and validation of a novel cuproptosis signature for stratifying different prognostic, immune, metabolic, and therapeutic landscapes in pancreati… First author DOI 10.26355/eurrev_202403_35617↗
  9. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  10. The age-dependent association of risk factors with pancreatic cancer. Co-author DOI 10.1016/j.annonc.2022.03.276↗
  11. Red meat consumption, cooking mutagens, NAT1/2 genotypes and pancreatic cancer risk in two ethnically diverse prospective cohorts. Co-author DOI 10.1002/ijc.33598↗
  12. A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer. Co-author DOI 10.1016/j.ajhg.2021.09.002↗
  13. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
  14. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
  15. Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-21-0400↗
  16. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Co-author DOI 10.1186/s13073-020-00816-4↗
  17. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
  18. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗
  19. Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0091↗
  20. Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Co-author DOI 10.1158/1055-9965.epi-20-0275↗
  21. Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0651↗
  22. Replication and Genetic Risk Score Analysis for Pancreatic Cancer in a Diverse Multiethnic Population. Co-author DOI 10.1158/1055-9965.epi-20-0963↗
  23. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
  24. Prospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk. First author DOI 10.1002/ijc.31574↗
  25. Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study. Co-author DOI 10.1093/carcin/bgy072↗
  26. Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry. Co-author DOI 10.1158/1055-9965.epi-17-0755↗
  27. Physical Activity and Pancreatic Cancer Risk among Urban Chinese: Results from Two Prospective Cohort Studies. First author DOI 10.1158/1055-9965.epi-17-0895↗
  28. CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations. Co-author DOI 10.1158/1055-9965.epi-17-1065↗
  29. Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk. Last author DOI 10.1002/ijc.31007↗
  30. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Co-author DOI 10.18632/oncotarget.11041↗
  31. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.29590↗
  32. Vitamin D metabolic pathway genes and pancreatic cancer risk. Co-author DOI 10.1371/journal.pone.0117574↗
  33. Correction: vitamin d metabolic pathway genes and pancreatic cancer risk. Co-author DOI 10.1371/journal.pone.0129983↗
  34. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/ng.3052↗
  35. Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Co-author DOI 10.1136/gutjnl-2012-303477↗
  36. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Co-author DOI 10.1007/s10552-012-0078-8↗
  37. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Co-author DOI 10.1007/s10552-012-0138-0↗
  38. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. Co-author DOI 10.1371/journal.pone.0072311↗

Closest collaborators

The 25 strongest of 85 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiao‐Ou Shu · 11 shared papers, 2013–2024 · strength 1.00
  2. Lang Wu · 5 shared papers, 2018–2021 · strength 0.46
  3. Rachael Z. Stolzenberg‐Solomon · 5 shared papers, 2013–2024 · strength 0.43
  4. Qiuyin Cai · 4 shared papers, 2017–2024 · strength 0.43
  5. Veronica Wendy Setiawan · 3 shared papers, 2020–2024 · strength 0.42
  6. Yu‐Tang Gao · 4 shared papers, 2017–2024 · strength 0.41
  7. Hui Cai · 3 shared papers, 2018–2024 · strength 0.35
  8. Gloria M. Petersen · 5 shared papers, 2013–2022 · strength 0.30
  9. William J. Blot · 3 shared papers, 2018–2021 · strength 0.29
  10. Xiang Shu · 3 shared papers, 2018–2021 · strength 0.25
  11. YH Zhang · 1 shared paper, 2024 · strength 0.24
  12. X. Yan · 1 shared paper, 2024 · strength 0.24
  13. David Daniel Bogumil · 2 shared papers, 2020–2021 · strength 0.23
  14. Stephen Jacob Pandol · 2 shared papers, 2020–2021 · strength 0.23
  15. Roger Laughlin Milne · 3 shared papers, 2018–2022 · strength 0.22
  16. Harvey A. Risch Risch · 3 shared papers, 2018–2022 · strength 0.22
  17. Paige M. Bracci · 3 shared papers, 2018–2022 · strength 0.22
  18. Charles L Kooperberg · 3 shared papers, 2013–2022 · strength 0.19
  19. Fei Ye · 1 shared paper, 2024 · strength 0.19
  20. Cong Wang · 1 shared paper, 2024 · strength 0.19
  21. Jordan D. Berlin · 1 shared paper, 2024 · strength 0.19
  22. Donghui Li · 3 shared papers, 2018–2020 · strength 0.18
  23. Jirong Long · 2 shared papers, 2020–2021 · strength 0.18
  24. Jingjing Zhu · 2 shared papers, 2020–2021 · strength 0.18
  25. Duo Liu · 2 shared papers, 2020–2021 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.